Answers are grounded in this paper and cite their sources.
4-Hydroxy-4, 7-dimethyl-α.-tetralone (1), 4,5-dihydroblumenol A (2), N.-trans.-feruloyltyramine (3), and 24–methylenelanosta-7, 9(11)-dien-3-β., 15α.-diol (4) were isolated from the stem bark of Polyalthia jucunda. (Piere) Finet & Gagnep (Annonaceae). All the compounds were evaluated for their effects on growth of four human tumor cell lines [ER(+) MCF-7, ER(−) MDA-MB-23, SF 268, and NCI-H460] and of a non–tumor cell line (MRC-5). Only compound 4 exhibited a dose-dependent growth inhibitory effect against both tumor and non–tumor cell lines but with less effect on the latter. Using the TUNEL assay, it was found that the inhibitory effect of compound 4 on NCI-H460 cells was probably caused by apoptosis.
No takes yet. Share an insight, caveat, or question.
Suedee et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: